Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues and passengers I chatted with on airplanes: Is Ozempic right for me? Or any of the blockbuster weight loss and diabetes drugs that recently caught the world’s attention?

Jim Gaffigan isn't ashamed to admit he jumped on the weight-loss medication bandwagon. In a new interview, the comedian revealed that when the scale hit 270 pounds last year, he decided to start taking Mounjaro,

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died after using the jab twice.

Jim Gaffigan reveals his weight loss journey with Mounjaro tackling food addiction and societal stigma while balancing comedy parenting and new ventures

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes Streeting announced last month that US drug manufacturer Eli Lilly will begin a five-year trial in Greater Manchester to test if the company’s weight loss drug could curb the UK’s unemployment crisis.

Jim Gaffigan exclusively told Us Weekly about using the weight loss drug Mounjaro and why food addiction gets "less sympathy"

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or Zepbound.

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight management but for many people, there are still questions around side effects, accessibility and results.

Jim Gaffigan has revealed using a weight-loss drug gave him a "better life". The comedian wants to challenge the stigma attached to using weight-loss injections after he successfully shed 50 pounds using the weight-loss drug Mounjaro.